Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Drug Eluting Stent Market, by Application
1.4.2 North America Drug Eluting Stent Market, by Coating Type
1.4.3 North America Drug Eluting Stent Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. North America Drug Eluting Stent Market by Application
4.1 North America Coronary Artery Disease Market by Country
4.2 North America Peripheral Artery Disease Market by Country
Chapter 5. North America Drug Eluting Stent Market by Coating Type
5.1 North America Polymer-based Coating Market by Country
5.2 North America Drug Eluting Stent Market by Polymer-based Coating Type
5.2.1 North America Non-biodegradable Polymers Market by Country
5.2.2 North America Biodegradable Polymers Market by Country
5.3 North America Polymer-free Coating Market by Country
5.4 North America Drug Eluting Stent Market by Polymer-free Coating Type
5.4.1 North America Micro Porous Surface Market by Country
5.4.2 North America Micro Structured Surface Market by Country
5.4.3 North America Slotted Tubular Surface Market by Country
5.4.4 North America Nanoporous Surface Market by Country
Chapter 6. North America Drug Eluting Stent Market by Country
6.1 US Drug Eluting Stent Market
6.1.1 US Drug Eluting Stent Market by Application
6.1.2 US Drug Eluting Stent Market by Coating Type
6.1.2.1 US Drug Eluting Stent Market by Polymer-based Coating Type
6.1.2.2 US Drug Eluting Stent Market by Polymer-free Coating Type
6.2 Canada Drug Eluting Stent Market
6.2.1 Canada Drug Eluting Stent Market by Application
6.2.2 Canada Drug Eluting Stent Market by Coating Type
6.2.2.1 Canada Drug Eluting Stent Market by Polymer-based Coating Type
6.2.2.2 Canada Drug Eluting Stent Market by Polymer-free Coating Type
6.3 Mexico Drug Eluting Stent Market
6.3.1 Mexico Drug Eluting Stent Market by Application
6.3.2 Mexico Drug Eluting Stent Market by Coating Type
6.3.2.1 Mexico Drug Eluting Stent Market by Polymer-based Coating Type
6.3.2.2 Mexico Drug Eluting Stent Market by Polymer-free Coating Type
6.4 Rest of North America Drug Eluting Stent Market
6.4.1 Rest of North America Drug Eluting Stent Market by Application
6.4.2 Rest of North America Drug Eluting Stent Market by Coating Type
6.4.2.1 Rest of North America Drug Eluting Stent Market by Polymer-based Coating Type
6.4.2.2 Rest of North America Drug Eluting Stent Market by Polymer-free Coating Type
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Mergers & Acquisition:
7.1.6 SWOT Analysis
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Terumo Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations & Agreements:
7.3.6 SWOT Analysis
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Trials and Approvals:
7.4.5.2 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.5.3 SWOT Analysis
7.6 Cook Medical, Inc. (Cook Group)
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 B. Braun Melsungen AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Biotronik SE & Co. KG
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Lepu Medical Technology Co., Ltd
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Alvimedica
7.10.1 Company Overview
7.10.2 SWOT Analysis
Unique Offerings 